The Senate Subcommittee on Antitrust Competition Policy and Consumer Rights held a hearing July 30 to explore contact lens pricing strategies initiated recently by contact lens manufacturers that would affect retail price competition, Sen. Amy Klobuchar (D-Minn.) said as she presided over the proceedings.“This is intended as an exploratory hearing to give the subcommittee and regulators a better understanding of the reasons for the minimum pricing arrangements in this particular market,” Sen. Michael S. Lee (R-Utah) said at the hearing. “Price matters in this market. I’ve heard that as prices (Read more...)
Allergan files lawsuit against Valeant, Pershing Square for federal securities violations
Allergan has filed a lawsuit in the U.S. District Court against Valeant Pharmaceuticals, Pershing Square Capital Management, and its principal, William A. Ackman, citing violations to federal securities laws prohibiting insider trading, engagement in fraudulent practices and failure to disclose legally required information.The complaint alleges that between February and April 2014, Pershing Square purchased Allergan stock and securities valued at more than $3.2 billion from unknowing Allergan stockholders, with full understanding of Valeant’s non-public takeover intensions.
ICD-10 implementation date set for Oct. 1, 2015
After a long wait, CMS has confirmed Oct. 1, 2015 as the implementation date for the use of ICD-10 codes. Controversy has surrounded the new coding system for its higher level of detail and the delay in setting a date for its implementation.
Kala initiates phase 2 trials for RVO, DME treatment
Kala Pharmaceuticals announced the initiation of a phase 2 clinical trial of KP-121, its loteprednol etabonate mucus penetrating particle platform, in patients with retinal vein occlusion and diabetic macular edema.The company is also launching a phase…
BLOG: Managing associate optometrists in your practice, part 4
As with eye surgeons, not all optometrists are created equally. It’s a broad but true generalization that younger ODs are better trained and equipped to step into a busy ophthalmic practice. Sparky doctors, both in intelligence and energy, can see more patients than dull docs.Recruiting a high-quality optometrist is generally much easier than finding a top-flight ophthalmologist. It pays to aim for a higher-quality doctor; small increments in compensation can yield large benefits in productivity and ease of management. Here’s a sample ad with all the right buzz words
Reading glasses not necessary with vision-correcting display
What if computer screens had glasses instead of the people staring at the monitors? That concept is not too far afield from technology being developed by UC Berkeley computer and vision scientists.